Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system
about
Pharmacovigilance Using Clinical NotesA modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions."First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.Developing alerting thresholds for prospective drug safety monitoring.Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.Development of a detection algorithm for statin-induced myopathy using electronic medical records.Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel.Strength of evidence for labeled dosing recommendations in renal impairment.Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin.Pharmacovigilance using Clinical Text.Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research.Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.Advancing the science of pharmacovigilance.
P2860
Q30058397-BAA63914-099A-4C1F-8913-AB80914B2A1DQ30812957-D2A7EEAA-7328-4B7B-930A-F7BF580CCE31Q30979182-AC933EB4-D676-477A-B9B4-CFEAA5E18649Q34430193-CFDE35A1-24E9-42C0-B1C0-3410A89E632CQ35089550-02381DA7-225A-42C2-BA37-F8184F3DD8F3Q35848816-FA29CF86-F878-43E0-A625-A1B737FEA062Q36859634-CAB1BE7E-E1F6-4E47-BC9C-182C99B271EBQ38093266-48DDA0F3-C9FC-49DF-BC8B-D5A2B3E1D882Q38127002-D6D37942-A2AA-4428-B4ED-9818F672CE3EQ39250007-D83BEB14-687B-4BC2-B34D-0A5778B177B9Q40185232-F223F788-2157-478C-9BC5-CE1207E3DCB9Q40449888-CF9856F1-3FE1-4308-B61E-BAEC2ACC8BFFQ42925545-50F7EC66-AC56-43F9-83E0-8FBCC3D1C7A2Q46262689-DFCF809C-3BB0-49B6-9EAF-0717A0A6B473Q47369849-981038D9-4F26-40BA-A5DB-B306A3BABE99Q51214332-3743CA2E-E0A9-4FA1-90AD-7D5C9B113C00
P2860
Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Active safety monitoring of ne ...... mi-automated monitoring system
@ast
Active safety monitoring of ne ...... mi-automated monitoring system
@en
type
label
Active safety monitoring of ne ...... mi-automated monitoring system
@ast
Active safety monitoring of ne ...... mi-automated monitoring system
@en
prefLabel
Active safety monitoring of ne ...... mi-automated monitoring system
@ast
Active safety monitoring of ne ...... mi-automated monitoring system
@en
P2093
P2860
P356
P1476
Active safety monitoring of ne ...... mi-automated monitoring system
@en
P2093
A M Walker
G W Daniel
J A Rassen
S Schneeweiss
P2860
P2888
P356
10.1038/CLPT.2011.369
P407
P577
2012-05-16T00:00:00Z
P5875
P6179
1020003384